Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance: A Narrative Review

Platinum-based chemotherapy has been the standard of care for ovarian cancer for the past 3 decades. Although most patients respond to platinum-based treatment, emergence of platinum resistance in recurrent ovarian cancer is inevitable during the disease course. Outcomes for patients with platinum-r...

Celý popis

Podrobná bibliografia

Vydané v:	JAMA oncology Ročník 9; číslo 6; s. 851
Hlavní autori:	Richardson, Debra L, Eskander, Ramez N, O'Malley, David M
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.06.2023
Predmet:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab - therapeutic use Carcinoma, Ovarian Epithelial - drug therapy Female Humans Neoplasm Recurrence, Local - drug therapy Ovarian Neoplasms - drug therapy Platinum - therapeutic use
ISSN:	2374-2445, 2374-2445
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!